background
human
rhinovirus
hrv
common
caus
viral
ill
worldwid
today
less
half
strain
sequenc
hand
examin
structur
viral
supergroup
known
decad
still
face
full
forc
molecular
biolog
onslaught
howev
newli
identifi
virus
niv
includ
human
metapneumoviru
bocaviru
emerg
virus
includ
sarscov
alreadi
exhaust
scrutin
clinic
impact
respiratori
niv
attribut
one
two
major
strain
distinct
hrv
never
sought
independ
must
arbitrarili
divid
literatur
clinic
impact
find
among
earli
find
infect
studi
use
ineffici
detect
method
shape
way
think
common
cold
virus
today
object
review
past
hrvrelat
studi
order
put
recent
hrv
discoveri
context
result
hrv
infect
result
undu
antibiot
prescript
sizabl
healthcarerel
expenditur
exacerb
expiratori
wheez
associ
hospit
admiss
conclus
find
mani
diverg
previous
unrecogn
hrv
strain
drawn
attent
resourc
back
widespread
frequent
infecti
agent
human
provid
us
chanc
seiz
advantag
decadeslong
cold
war
appear
singl
diseas
capabl
singl
solut
turn
someth
unimagin
complex
straightforward
answer
david
tyrrel
michael
fielder
cold
war
fight
common
cold
oxford
univers
press
picornavirus
common
caus
viral
ill
worldwid
rotbart
hayden
rhinovirus
hrv
previous
call
coryzavirus
echo
erc
murivirus
enteroviruslik
virus
nasal
secret
agent
salisburi
strain
jackson
dowl
andrew
hamr
tyrrel
parson
common
caus
acut
respiratori
tract
ill
arti
upper
respiratori
tract
urt
infect
tradit
defin
common
cold
arti
lead
caus
morbid
children
year
bryce
et
al
symptom
pathognomon
hrv
infect
phillip
et
al
baer
et
al
van
den
hoogen
et
al
devolv
diagnost
laboratori
confirm
presenc
hrv
barrett
et
al
disappointingli
routin
screen
hrv
strain
occur
infrequ
test
alway
avail
ii
hrv
infect
often
consid
innocu
iii
treatment
avail
end
centuri
mani
aspect
hrv
epidemiolog
immunobiolog
strain
character
clinic
impact
remain
poorli
address
couch
monto
et
al
nonetheless
hrv
common
reason
prescrib
antibiot
treat
respiratori
ill
even
bacteri
infect
rotbart
hayden
relat
cost
exceed
billion
annual
bertino
hrv
also
commonli
identifi
pathogen
associ
expiratori
wheez
exacerb
anoth
burden
healthcar
resourc
mani
level
nyquist
et
al
papadopoulo
et
al
jacqu
et
al
rotbart
hayden
monto
jartti
et
al
hrv
respiratori
virus
socal
predomin
detect
human
urt
occasion
lower
respiratori
tract
lrt
circul
respiratori
virus
commonli
vari
time
across
distanc
influenc
number
strain
strength
distinct
immunogen
legion
antigen
distinct
hrv
strain
stymi
search
answer
epidemiologyrel
question
decad
andrew
result
hrv
frequent
dismiss
singl
group
subtl
variant
mani
past
hrv
studi
conduct
without
advantag
modern
molecular
biolog
knowledg
mani
endem
respiratori
virus
discov
sinc
applic
polymeras
chain
reaction
pcr
hrv
screen
seem
possibl
make
great
advanc
understand
hrv
infect
prior
detect
hrv
depend
subject
insensit
method
rang
deliber
human
infect
cell
organ
cultur
serolog
pcr
best
tool
current
better
character
hrv
appli
care
full
understand
limit
care
epidemiolog
play
pivot
role
understand
hrv
clinic
followup
hrv
pcr
posit
includ
asymptomat
individu
control
group
without
relev
respiratori
symptom
must
occur
handinhand
regular
frequent
sampl
expens
undertak
mani
diverg
previous
uncharacter
hrv
strain
identifi
arden
et
al
mcerlean
et
al
lamson
et
al
kistler
et
al
lau
et
al
mcerlean
et
al
use
molecular
techniqu
herein
account
molecular
age
use
strain
describ
genet
equival
serotyp
variant
describ
virus
strain
share
nucleotid
ident
detect
differ
individu
isol
differenti
detect
inabl
infer
infect
upon
latter
isol
propag
cultur
new
battl
underway
abund
equal
misunderstood
viral
foe
human
ever
known
fascin
littl
understood
battl
war
cold
one
quantifi
contribut
hrv
strain
ill
modifi
human
immun
system
review
touch
upon
major
area
hrv
research
provid
context
latest
surg
hrv
discoveri
lack
respons
antibiot
therapi
absenc
microscop
bodi
inocul
cultur
ineffect
filtrat
remov
causal
agent
suggest
viru
rather
bacterium
aetiolog
agent
common
cold
first
problemplagu
vitro
cultiv
hrv
strain
dc
report
andrew
et
al
properli
character
time
anoth
variant
given
offici
nomenclatur
tyrrel
kapikian
et
al
tyrrel
et
al
hamparian
et
al
conant
hamparian
hrv
name
associ
morbid
involv
human
nose
eventu
found
fill
causal
role
respiratori
ill
clinic
distinguish
genom
similar
hev
taylorrobinson
distinct
antigen
type
serotyp
recogn
collabor
rhinoviru
genom
structur
exemplifi
hrvqpm
genbank
access
number
includ
nucleotid
posit
separ
code
region
illustr
identifi
polyprotein
subsequ
precursori
matur
protein
name
fill
box
genom
structur
nonstructur
region
encompass
protein
cotransl
cleavag
approxim
kda
polyprotein
mediat
virusencod
proteas
pro
catalys
releas
free
region
subsequ
posttransl
cleavag
perform
proteas
pro
also
like
free
polyprotein
racaniello
three
region
commonli
contribut
taxonom
placement
underlin
dash
bar
b
singl
asymmetr
unit
includ
simplifi
visual
capsid
featur
symmetri
approxim
placement
canyon
bold
line
canyon
face
also
indic
subsurfac
bind
pocket
dash
grey
oval
indic
axe
symmetri
includ
small
fill
pentagon
indic
axi
small
oval
triangl
indic
axe
symmetri
c
depict
hrv
icosahedr
capsid
compris
smallest
capsid
unit
protom
viral
pentam
highlight
grey
shade
panel
compos
five
protom
hrv
assembl
capsid
icosahedron
hrv
virion
approxim
nm
diamet
rotbart
pair
face
protom
indic
c
darker
grey
panel
depict
crosssect
use
spacefil
format
protom
consist
singl
copi
three
expos
structur
protein
intern
structur
protein
stirk
thornton
rossmann
et
al
rotbart
bind
pocket
asterisk
usual
fill
pocket
factor
locat
beneath
canyon
distinct
deep
nm
cleft
site
major
receptor
interact
canyon
compris
mostli
residu
encircl
point
five
protom
come
togeth
creat
axi
rossmann
rossmann
et
al
canyon
rim
restrict
entri
nm
fab
portion
antibodi
molecul
evid
conserv
canyon
floor
sequest
away
immun
pressur
provid
safe
harbour
receptor
contact
among
major
known
hrv
strain
rossmann
et
al
pevear
et
al
e
top
view
ribbon
depict
five
protom
compris
viral
pentam
rel
orient
asymmetr
unit
indic
refer
adapt
mackay
et
al
pressa
laboratori
eventu
increas
dick
et
al
kapikian
et
al
hamparian
et
al
famili
picornavirida
pico
spanish
small
rna
ribonucl
acid
genom
current
compris
nine
genera
includ
enteroviru
rhinoviru
within
two
current
speci
human
rhinoviru
strain
human
rhinoviru
b
strain
hrv
strain
exhibit
amino
acid
ident
similar
antivir
suscept
pattern
although
recent
studi
indic
strain
may
distinct
enough
deserv
uniqu
name
ledford
et
al
propos
set
intern
committe
taxonomi
virus
ictv
merg
genera
rhinoviru
enteroviru
singl
genu
enteroviru
speci
remain
intact
banner
new
viru
order
picornaviral
le
gall
et
al
issu
merg
genera
one
content
decad
rosen
skern
et
al
stanway
et
al
hrv
subclassifi
use
tissu
tropism
host
rang
antivir
suscept
phylogeni
earli
sequenc
subgenom
rtpcr
amplicon
also
identifi
presenc
two
viral
clade
subsequ
defin
hrv
speci
mori
clewley
distinct
bifurc
retain
sequenc
subgenom
region
includ
fig
compar
today
sequenc
phylogenet
comparison
surrog
import
biolog
classif
criteria
savolainen
et
al
savolainen
et
al
ledford
et
al
lain
et
al
lain
et
al
king
et
al
hungn
et
al
tabl
hrv
capsid
contain
approxim
kb
rna
genom
fig
tend
adenin
uracil
u
rich
hugh
et
al
particularli
third
wobbl
codon
posit
code
region
bracket
untransl
region
utr
perform
regulatori
function
permit
genom
duplic
product
singl
multidomain
proteolyt
process
polyprotein
rueckert
wimmer
matur
capsid
protein
kda
kda
kda
exist
convolut
set
protein
sheet
loop
stirk
thornton
ledford
et
al
fig
loop
protrud
beyond
extern
capsid
surfac
contain
import
often
discontinu
antigen
site
four
neutral
antibodi
immunogen
nim
region
identifi
virion
locat
nimii
nimiii
rossmann
et
al
antigen
site
b
c
also
identifi
minor
group
viru
rossmann
et
al
picornavirus
recogn
varieti
receptor
rossmann
khan
et
al
uncaph
et
al
minor
group
hrv
strain
underlin
major
group
shown
bold
found
hrv
propens
monkey
cell
h
strain
locat
speci
grew
human
cell
cultur
gwaltney
jordan
stott
et
al
rosenbaum
et
al
tyrrel
parson
tyrrel
byno
ketler
et
al
taylorrobinson
tyrrel
cooney
kenni
bloom
et
al
indic
superscript
gener
correl
receptor
usag
macnaughton
assign
strain
subclassif
may
also
influenc
viral
load
inoculum
dougla
et
al
hamr
h
terminolog
abandon
favour
streamlin
sequenti
number
system
taylorrobinson
tyrrel
hrv
strain
later
divid
major
minor
group
defin
receptor
tropism
abraham
colonno
colonno
et
al
two
antivir
group
b
defin
suscept
antivir
molecul
reflect
amino
acid
sequenc
interact
region
andri
et
al
includ
tabl
although
variant
ishiko
et
al
despit
appar
sensit
acid
uncaph
et
al
hrvhank
may
serotyp
may
ledford
et
al
capsid
major
hrv
n
describ
major
group
abraham
colonno
interact
aminotermin
domain
kda
intercellular
adhes
molecul
icami
greve
et
al
staunton
et
al
rossmann
et
al
tomassini
et
al
receptor
bind
destabil
hrv
capsid
probabl
dislodg
pocket
factor
initi
uncoat
rossmann
et
al
kolatkar
et
al
rossmann
remain
minor
group
abraham
colonno
virus
employ
member
low
densiti
lipoprotein
receptor
ldlr
famili
attach
cell
hofer
et
al
bind
vldlr
occur
outsid
canyon
fig
ribbon
depict
protein
involv
predict
hrvqpm
pentam
construct
use
chimera
pettersen
et
al
deriv
mcerlean
et
al
view
b
singl
molecul
side
signific
surfaceexpos
loop
contain
import
antigen
site
box
flat
ribbon
arrowhead
coil
ribbon
northern
face
fig
employ
differ
destabilz
mechan
viru
uncoat
hrv
strain
usual
present
literatur
tightknit
group
virus
ident
clinic
impact
evid
suggest
closer
scrutini
individu
strain
warrant
hrv
strain
seem
circul
without
identifi
pattern
phillip
et
al
howev
appar
random
today
explain
complex
interact
mani
strain
host
genet
heterogen
uniqu
immun
repertoir
accru
person
popul
lifetim
rhinovir
exposur
new
infect
contribut
accumul
immun
decreas
symptom
sever
upon
reinfect
afford
complet
protect
challeng
homolog
strain
cate
et
al
bloom
et
al
host
immun
perceiv
strain
antigen
distinct
dougla
et
al
dick
et
al
immunogen
novelti
also
support
occurr
sequenti
infect
differ
hrv
strain
peltola
et
al
suggest
contrast
hev
evolut
hrv
strain
subject
signific
recombin
kistler
et
al
despit
opportun
provid
occurr
dual
infect
cooney
kenni
fact
hrv
strain
suggest
purifi
pressur
drive
minim
chang
time
apart
variat
site
immun
activ
recent
hrv
describ
may
result
recombin
event
region
two
hrv
strain
tapparel
et
al
nonetheless
hrv
strain
identifi
decad
earlier
retain
conserv
section
andeweg
et
al
make
good
region
molecular
type
hrv
strain
hand
proven
less
use
clearli
assign
hev
strain
current
speci
fig
brisban
identifi
contemporari
variant
hrv
strain
first
classifi
retain
amino
acid
nucleotid
ident
elder
namesak
region
data
deriv
arden
et
al
data
convincingli
identifi
distinct
clinic
outcom
singl
hrv
strain
mani
studi
detect
strain
less
frequent
tabl
seek
like
microbi
caus
even
span
suffici
time
encompass
possibl
hrv
strain
andri
et
al
suggest
antivir
group
b
strain
hrv
overrepres
among
symptomat
respiratori
infect
sri
ascrib
frequent
role
diseas
strain
could
also
attribut
greater
number
strain
group
practic
find
less
hrv
hrv
b
requir
infect
antibodyfre
adult
volunt
latter
also
produc
cold
milder
sever
hendley
et
al
birth
cohort
studi
note
infant
wheez
infect
one
hrv
strain
alway
wheez
second
fig
phylogeni
untransl
region
utr
nt
hrv
hev
sequenc
obtain
genbank
access
number
shown
review
region
also
divid
nt
fragment
third
hrv
infect
kusel
et
al
suggest
strain
may
asthmagen
yoo
et
al
poor
detect
hrv
strain
long
hindranc
character
cultur
proven
unreli
kaiser
et
al
larson
et
al
jartti
et
al
identif
larg
number
diverg
hrv
strain
suggest
prior
investig
detect
strain
other
extent
bia
may
contribut
signific
underestim
number
strain
capac
hrv
caus
ill
respiratori
viru
diagnost
tool
de
jour
pcr
posit
result
seldom
character
beyond
genu
level
usual
report
respiratori
picornavirus
hrv
hev
detect
respiratori
tract
serodiagnosi
impract
johnston
et
al
gwaltney
serolog
techniqu
could
role
gaug
extent
singl
hrv
strain
undergo
antigen
chang
year
year
nonetheless
antibodi
essenti
strainspecif
neutral
infect
techniqu
around
hrv
nomenclatur
system
evolv
conant
hamparian
techniqu
found
larg
number
distinct
strain
circul
year
select
predomin
given
season
replac
other
subsequ
year
andrew
andrew
cowork
common
cold
unit
salisburi
uk
describ
first
isol
hrv
strain
use
cell
particular
human
embryo
propag
fail
sourc
cell
exhaust
andrew
et
al
andrew
earli
vitro
isol
method
employ
interfer
test
determin
success
isol
cultur
suspect
infect
hrv
prevent
infect
anoth
readili
titrat
viru
andrew
later
price
jh
strain
pelon
et
al
strain
develop
improv
cultur
system
permit
viral
replic
easili
identifi
price
strain
initi
classifi
echovirus
echo
later
pelon
time
propag
hgp
tree
construct
compar
consecut
fragment
inset
grey
bar
repres
nt
fragment
black
bar
repres
complet
utr
branch
pattern
shown
retain
subtl
chang
hrv
speci
alway
repres
clearli
shown
hev
speci
muddl
nucleotid
sequenc
align
use
bioedit
hall
tree
construct
neighborjoin
analysi
resampl
use
mega
tamura
et
al
nodal
valu
shown
fell
hev
human
enteroviru
ev
echoviru
cv
coxsackieviru
hpv
human
polioviru
phillip
et
al
urt
ill
children
read
et
al
recurr
asthma
adult
militari
bloom
et
al
urt
ill
adult
outpati
suzuki
et
al
pvod
adult
militari
rosenbaum
et
al
common
cold
adult
offic
worker
arti
adult
lung
transplant
kaiser
et
al
graft
dysfunct
adult
ltcf
louie
et
al
lrt
ill
adult
surgeri
craighead
et
al
lrt
ill
postmortem
infant
urquhart
grist
urquhart
stott
sid
adult
isol
holm
et
al
lrt
ill
children
isol
stott
et
al
lrt
ill
urt
ill
children
krilov
et
al
lrt
ill
children
adult
reilli
et
al
artiab
neg
common
virus
ab
antibodi
arti
acut
respiratori
tract
infect
ili
influenzalik
ill
lrt
lower
respiratori
tract
ltcf
long
term
care
facil
pvod
postvir
olfactori
diseas
untyp
hrv
strain
sid
sudden
infant
death
syndrom
urt
upper
respiratori
tract
strain
result
use
increas
acid
lower
cultiv
temperatur
constant
motion
rotat
parson
tyrrel
despit
challeng
viru
isol
sensit
indic
infect
antibodi
rise
pair
sera
hendley
et
al
sever
cell
line
method
requir
encompass
viru
concentr
rang
tcid
ml
dougla
et
al
dalessio
et
al
cate
et
al
hendley
et
al
addit
control
cell
age
plate
h
inoculum
volum
medium
ph
cell
densiti
import
reproduc
appear
hrvinduc
plaqu
higher
viru
yield
sethi
gwaltney
behbehani
lee
fiala
kenni
hrv
grow
temperatur
c
roll
c
preced
h
stationari
incub
period
parson
tyrrel
produc
highest
yield
fastest
vitro
viral
growth
papadopoulo
et
al
rosenbaum
et
al
andrew
behbehani
lee
improv
sensit
pcrbase
assay
dramat
increas
frequenc
hrv
detect
compar
cultiv
method
vesa
et
al
et
al
andeweg
et
al
arruda
et
al
renwick
et
al
becom
commonplac
find
hrv
predomin
viru
arti
case
aberl
et
al
versteegh
et
al
hutchinson
et
al
pcr
assay
complet
valid
picornaviru
strain
use
clinic
materi
pedant
nonetheless
necessari
process
yet
mani
success
detect
current
circul
hrv
strain
level
low
tcid
sampl
amount
commonli
shed
experiment
inocul
studi
arruda
hayden
lu
et
al
hrv
strain
detect
beyond
commonli
understood
symptomat
context
johnston
et
al
suvilehto
et
al
import
defin
qualit
quantit
correl
viral
nucleic
acid
detect
presenc
infecti
viru
sampl
site
problem
use
pcr
studi
respiratori
virus
today
commonli
employ
oligonucleotid
compris
gama
assay
gama
et
al
remain
forefront
detect
respiratori
picornavirus
torgersen
et
al
gern
et
al
spenc
et
al
winther
et
al
arruda
hayden
xatzipsalti
et
al
papadopoulo
et
al
b
khetsuriani
et
al
arruda
et
al
et
al
et
al
johnston
et
al
blomqvist
et
al
noksokoivisto
et
al
kusel
et
al
seemung
et
al
howev
subtl
reposit
primer
chang
method
employ
collinson
et
al
deffernez
et
al
jartti
et
al
may
detriment
assay
perform
suggest
predict
hybridis
mismatch
unusu
reduc
detect
frequenc
oligonucleotid
use
hrv
studi
includ
hayden
et
al
wright
et
al
steining
et
al
billaud
et
al
et
al
freymuth
et
al
halonen
et
al
blomqvist
et
al
blomqvist
et
al
vesa
et
al
coira
et
al
common
gama
assay
diagnost
oligonucleotid
use
hrv
pcrbase
studi
share
ident
hev
sequenc
vice
versa
leparc
et
al
lina
et
al
hand
lu
assay
lu
et
al
function
suitabl
realtim
pcr
altern
use
epidemiolog
studi
seek
better
repres
respiratori
picornaviru
preval
use
oligoprob
increas
amplicon
detect
sensit
specif
identifi
fewer
tcid
ml
fewer
genom
copi
agaros
gel
detect
amplicon
johnston
et
al
et
al
lu
et
al
includ
test
menu
hrv
detect
rais
frequenc
pathogen
detect
one
per
sampl
brunstein
et
al
earli
hrv
studi
found
hrv
strain
frequent
contributor
coinfect
conclud
evid
minor
role
seriou
respiratori
ill
stott
et
al
like
reflect
insensit
cultur
method
use
simpli
fail
propag
mani
hrv
strain
today
half
hrv
detect
found
concurr
anoth
viru
surfac
signific
fraction
yet
human
respiratori
syncyti
viru
hrsv
human
metapneumoviru
hmpv
hev
influenzaviru
ifv
detect
human
coronaviru
hcov
detect
found
compani
anoth
viru
richard
et
al
consid
ubiqu
interest
rel
low
number
concurr
detect
respiratori
virus
occur
hrv
strain
mackay
lambert
et
al
support
concept
hrv
direct
role
clinic
outcom
infect
miller
et
al
fact
hrv
strain
codetect
pathogen
reproduc
clinic
undefin
pattern
brunstein
et
al
hrv
partnership
host
immun
may
mutualist
one
inadvert
impart
advantag
host
protect
cytopath
respiratori
viral
pathogen
host
provid
vessel
hrv
replic
transmiss
novel
multitarget
molecular
laboratori
tool
includ
multicodeplx
system
employ
synthet
nucleobas
pair
multiplex
pcr
microspher
flow
cytometri
nolt
et
al
permit
discret
detect
viral
target
two
assay
control
although
return
untyp
low
hrv
detect
rate
similar
technolog
also
provid
sensit
rtpcrbase
assay
mahoni
et
al
novel
approach
amplicon
detect
entitl
masstag
per
sampl
discrimin
viral
pcr
product
bries
et
al
use
oligonucleotid
tag
uniqu
compound
releas
via
photolabil
link
qiagen
masstag
approach
success
identifi
novel
hrv
sequenc
renwick
et
al
lamson
et
al
microarray
detect
thousand
viral
target
per
sampl
sensit
enough
avoid
prehybridis
pcr
amplif
use
clinic
specimen
robust
microarray
like
pcr
reli
exist
conserv
region
sequenc
detect
unknown
virus
succeed
detect
previous
unknown
hrv
strain
wang
et
al
rapid
proteinor
virionbas
assay
yet
adequ
sensit
ostroff
et
al
shanmukh
et
al
hrv
detect
occur
throughout
year
usual
peak
spring
autumn
winther
et
al
vesa
et
al
silva
et
al
miller
et
al
gwaltney
et
al
fox
et
al
lambert
et
al
jartti
et
al
depend
detect
tool
employ
length
studi
period
type
popul
investig
phillip
et
al
wald
et
al
one
studi
indic
given
strain
may
lead
time
provid
warn
impend
epidem
strain
dick
et
al
identifi
anoth
purpos
strain
type
data
address
whether
everi
strain
recur
year
singl
locat
herd
immun
protect
reinfect
previou
epidem
strain
long
effect
might
last
found
brisban
hrv
b
strain
circul
winter
wherea
hrv
occur
season
novel
hrv
clade
hrv
predominantli
circul
spring
arden
et
al
return
long
school
univers
holiday
frequent
trigger
hrv
epidem
activ
young
alsunaidi
et
al
hamr
et
al
johnston
et
al
season
variat
preval
viru
may
influenc
interfer
wherebi
peak
preval
one
respiratori
viru
moder
prevent
process
let
one
virus
establish
time
glezen
denni
report
rate
hrv
infect
tabl
vari
manner
ill
defin
record
document
aetiolog
track
longitudin
lemansk
et
al
detect
rate
data
comprehens
repres
hrv
circul
pattern
sequenti
infect
differ
strain
occur
may
appear
unbroken
symptomat
episod
singl
observ
period
fig
phillip
et
al
minor
et
al
occurr
rare
examin
instanc
multipl
hrv
strain
isol
cooney
kenni
cooney
et
al
detect
renwick
et
al
lee
et
al
peltola
et
al
singl
specimen
indic
capac
hrv
coinfect
hrv
shed
commonli
limit
day
period
immunocompet
subject
although
shed
ill
may
detect
even
experiment
inocul
kaiser
et
al
dougla
et
al
rosenbaum
et
al
suzuki
et
al
dick
et
al
arruda
et
al
adult
children
usual
asymptomat
day
postinfect
cate
et
al
chronic
carriag
commonli
occur
children
detect
picornaviru
rna
rtpcr
reportedli
extend
week
onset
time
child
defin
asymptomat
week
winther
et
al
shown
tabl
hrv
alon
detect
asymptomat
popul
yet
seem
rosenbaum
et
al
per
month
cultur
per
month
infant
viru
lemansk
et
al
per
month
pcr
mild
sever
children
microorgan
collinson
et
al
year
per
month
pcr
year
per
month
children
pv
winther
et
al
per
childmonth
pcr
children
hrv
miller
et
al
per
per
year
pcr
isol
commun
common
cold
paul
frees
per
year
bacteri
cultur
observ
isol
commun
common
cold
milam
smilli
per
year
bacteri
cultur
observ
home
care
wald
et
al
per
year
observ
group
care
wald
et
al
per
year
day
care
wald
et
al
per
year
hrv
human
rhinoviru
pcr
polymeras
chain
reaction
pv
picornaviru
overrepres
amongst
claim
detect
make
viru
innocu
passeng
host
isol
hrv
strain
two
discret
occas
report
among
militari
recruit
one
strain
isol
intermitt
period
rosenbaum
et
al
among
healthi
adult
length
excret
signific
howev
cultiv
failur
intermedi
sampl
lower
viral
load
heterotyp
crossreact
influenc
strain
type
system
exclud
viral
rna
detect
usual
conduct
absenc
strain
type
suggest
occur
day
five
week
symptom
commenc
ceas
respect
winther
et
al
jartti
et
al
et
al
implic
sampl
taken
sri
could
hrvneg
sampl
outsid
period
may
detect
viru
absenc
symptom
winther
et
al
unfortun
data
avail
address
sinc
clinic
followup
rare
suvilehto
et
al
parent
maintain
daili
symptom
diari
respiratori
picornviru
rtpcr
posit
character
three
differ
hrv
strain
could
identifi
singl
subject
period
replic
strain
indic
grey
box
strain
ident
provid
left
type
perform
sampl
occur
intermitt
indic
shape
exampl
triangl
circl
squar
laboratori
data
could
suggest
one
two
infect
test
perform
symptomat
period
usual
studi
start
conclus
studi
period
exampl
accur
determin
hrv
infect
frequenc
strain
divers
would
possibl
exampl
identifi
case
sampl
cessat
studi
would
identifi
hrvbb
strain
howev
symptom
could
appar
due
soontobedetect
detect
indic
fill
circl
replic
strain
bb
may
prohibit
signific
replic
indic
breviti
infect
period
due
preexist
immun
result
asymptomat
state
still
yield
relev
posit
detect
exampl
sampl
conduct
sri
hrv
bb
detect
b
hrvk
truli
chronic
infect
singl
strain
wherea
hrvtc
exemplifi
culturebas
studi
strain
appear
recur
period
absenc
individu
studi
design
could
conclud
persist
shed
occur
confound
attempt
correl
symptomat
period
individu
hrv
strain
perpetu
belief
hrv
exist
independ
group
kusel
et
al
hcov
hpiv
hmpv
hrsv
hadv
childrenadult
pcr
pv
johnston
et
al
nd
children
pcr
pv
winther
et
al
n
adult
cultur
hrv
ifv
hpiv
hrsv
adult
cultur
filter
agent
jackson
dowl
n
children
pcr
hrv
suvilehto
et
al
n
children
cultur
hrv
banham
hpiv
hev
hadv
adult
cultur
hamr
et
al
hcov
hrsv
flubv
hpiv
hadv
children
year
pcr
hrv
rake
et
al
hrsv
hadv
children
pcr
pv
jartti
et
al
examin
children
cultur
stott
et
al
hrsv
hrv
hpiv
hsv
hadv
hev
posit
associ
ill
howev
asymptomat
period
may
also
associ
underreport
true
sri
winther
et
al
one
conclud
essenti
sampl
often
accur
hrv
epidemiolog
epidemiolog
employ
pcr
togeth
molecular
genotyp
usual
identifi
chronic
shed
peltola
et
al
like
occurr
serial
concurr
infect
multipl
strain
dick
et
al
rosenbaum
et
al
one
must
therefor
cautiou
describ
persist
hrv
infect
kling
et
al
absenc
strain
type
investig
implic
persist
featur
individu
hrv
strain
viru
shed
normal
ceas
within
day
gern
et
al
like
plan
link
hrv
posit
asymptomat
carriag
otherwis
healthi
individu
requir
care
construct
aim
regular
frequent
sampl
clinic
score
system
capabl
determin
real
asymptomat
state
current
data
indic
truli
chronic
shed
month
singl
hrv
strain
limit
individu
underli
immunosuppress
immun
dysfunct
kaiser
et
al
nasopharynx
identifi
major
site
focal
viru
product
regardless
experiment
inocul
rout
winther
et
al
therefor
much
data
identifi
specimen
type
transmiss
rout
arisen
studi
urt
ill
point
inocul
conjunctiv
sac
absenc
neutral
antibodi
result
activ
infect
nasal
mucosa
viru
carri
nasolacrim
duct
winther
et
al
experiment
inocul
studi
viru
commonli
deliv
aerosol
intranas
instil
ml
viru
suspens
dougla
et
al
winther
et
al
hendley
et
al
turner
et
al
dalessio
et
al
cate
et
al
nasopharyng
wash
yield
better
viral
isol
rate
either
nasal
pharyng
swab
conveni
swab
meant
use
widespread
cate
et
al
gwaltney
et
al
peltola
et
al
especi
presenc
viabl
hrv
necessari
viru
identif
high
frequenc
clinic
cold
low
transmiss
thought
enigmat
andrew
andrew
featur
earli
hrv
epidemiolog
larg
demystifi
today
current
knowledg
strain
grasp
immunolog
involv
identif
asymptomat
infect
vastli
improv
diagnost
sensit
past
household
crossinfect
determin
sri
low
five
exposur
infect
member
requir
infect
lidwel
sommervil
despit
viral
load
nasal
wash
peak
tcid
ml
dougla
et
al
experiment
transmiss
also
reportedli
ineffici
dalessio
et
al
contrast
natur
closequart
militari
popul
interact
week
experienc
rapid
spread
hrv
strain
group
rosenbaum
et
al
use
pcr
recent
clarifi
discrep
confirm
frequent
transmiss
famili
common
culturebas
studi
identifi
often
result
asymptomat
infect
among
older
sibl
parent
peltola
et
al
laboratori
hrv
retain
infect
hour
day
suitabl
surfac
hendley
et
al
support
practic
possibl
selfinocul
via
fomit
hendley
gwaltney
handwash
disinfect
wipe
like
method
interrupt
transfer
fomit
nose
conjunctiva
hendley
gwaltney
winther
et
al
howev
eyerub
nosepick
occur
frequent
hendley
et
al
suggest
inocul
could
outpac
person
hygien
transmiss
hrv
largeand
smallparticl
aerosol
gener
proven
ineffici
support
low
isol
rate
saliva
compar
hand
wash
nasal
swab
dougla
et
al
hendley
et
al
particip
expos
larg
particl
aerosol
fact
wild
hrv
strain
induc
cold
spread
less
effect
due
coxsackieviru
infect
couch
et
al
apart
particl
size
aerosol
spread
may
conting
upon
nasal
obstruct
divert
secret
nare
contamin
saliva
presumpt
sourc
viru
sneez
cough
dougla
et
al
expos
l
smallparticl
aerosol
tcid
associ
fever
promin
tracheobronch
antibodyfre
adult
volunt
deliv
via
nasal
drop
coars
aerosol
cate
et
al
hrv
implic
mani
respiratori
tractrel
diseas
entiti
ill
usual
frequent
sever
longerlast
children
immunocomprom
elderli
healthi
immunocompet
adult
atmar
wald
et
al
dick
et
al
addit
presenc
infant
children
household
doubl
attack
rate
adult
lidwel
sommervil
way
symptom
use
defin
ill
influenc
specimen
collect
sourc
variabl
affect
studi
address
impact
hrv
replic
host
also
investig
common
cold
treatment
gwaltney
et
al
ill
defin
presenc
one
symptom
time
period
winther
et
al
minimum
consecut
h
period
spenc
et
al
symptom
score
predefin
threshold
perhap
preced
suitabl
met
clinic
criteria
johnston
et
al
specimen
may
collect
sri
spenc
et
al
johnston
et
al
time
per
week
laboratori
analysi
minor
et
al
twice
daili
physiolog
measur
respiratori
function
johnston
et
al
conclus
sri
period
sri
rang
seven
symptomfre
day
rosenbaum
et
al
day
hrv
identif
underreport
clinic
criteria
alon
use
defin
viral
activ
fig
symptom
scorecard
diari
maxim
prospect
collect
homebas
data
visit
studi
investig
johnston
et
al
lambert
et
al
homebas
symptom
record
falter
difficulti
identifi
ill
time
manner
shortcom
subject
method
identifi
minim
employ
frequent
laboratori
analysi
winther
et
al
johnston
et
al
cost
arti
recogn
term
patient
famili
expenditur
includ
prescript
nonprescript
medic
gener
practition
visit
healthcar
sector
cost
includ
drug
consult
subsidi
special
hospit
equip
purchas
emerg
depart
resourc
less
import
cost
includ
time
spent
away
carer
usual
activ
reduct
carer
perform
effici
loss
product
also
consider
common
cold
princip
selflimit
subject
coryz
ill
creat
sizabl
annual
econom
burden
lidwel
sommervil
jackson
dowl
turner
cold
princip
outcom
attribut
hrv
infect
obviou
pattern
symptom
report
lidwel
sommervil
bloom
et
al
gern
et
al
common
cold
tempor
associ
detect
respiratori
picornavirus
major
hrv
andrew
arruda
et
al
howev
respiratori
virus
also
associ
urt
syndrom
ill
includ
hcov
around
detect
ifv
hrsv
human
adenovirus
andrew
andrew
pizzichini
et
al
eccl
hrv
strain
detect
use
pcr
specimen
children
follow
first
year
life
increas
risk
urt
ill
presenc
hrsv
kusel
et
al
symptom
develop
within
day
holm
et
al
includ
sneez
nasal
discharg
rhinorrhoea
nasal
congestionblockag
sore
irrit
throat
headach
cough
feel
fever
chilli
headach
malais
winther
et
al
rosenbaum
et
al
hoars
loss
tast
smell
bodi
ach
pain
mild
burn
eye
feel
pressur
ear
sinus
due
obstruct
andor
mucos
swell
may
also
occur
anorexia
loos
bowel
neutrophilia
note
among
experiment
infect
adult
volunt
cate
et
al
cate
et
al
dougla
et
al
earli
elev
viral
shed
adult
associ
reduc
incub
period
sever
sri
dougla
et
al
measur
increas
temperatur
like
occur
children
adult
fever
found
among
either
group
dick
et
al
andrew
miller
et
al
addit
clinic
sensit
may
achiev
children
sampl
episod
atyp
symptom
includ
uncharacterist
irrit
disturb
sleep
pattern
feed
difficulti
due
snuffl
increas
antibiot
resist
among
bacteria
result
unnecessarili
treat
larg
number
children
predominantli
viral
urt
ill
expiratori
wheez
acut
bronchiti
soyka
et
al
schwartz
et
al
arnold
et
al
mucopurul
rhiniti
natur
compon
viral
rhinosinus
antibiot
often
prescrib
assur
parent
physician
someth
done
yet
condit
deriv
littl
benefit
antibacteri
intervent
miller
et
al
nyquist
et
al
soyka
et
al
obrien
et
al
use
antibiot
treat
selflimit
ill
unwarr
sinc
sideeffect
pronounc
neg
rather
posit
impact
health
gadomski
rosenstein
et
al
todd
et
al
aom
frequent
reason
outpati
antibiot
therapi
unit
state
recent
consid
princip
bacteri
aetiolog
heikkinen
chonmaitre
howev
urt
infect
involv
bacteria
commonli
accompani
viral
detect
lehtinen
et
al
isol
pcr
detect
virus
middl
ear
fluid
evan
et
al
failur
grow
bacteria
hrvposit
fluid
even
absenc
antibiot
treatment
sung
et
al
refractori
natur
aom
case
antibiot
therapi
indic
virus
play
role
ill
picornavirus
detect
nasopharyng
swab
taken
symptomat
asymptomat
aompron
infant
young
children
larg
quantiti
hrv
rna
detect
situ
hybridis
adenoid
tissu
children
recurr
aom
et
al
rihkanen
et
al
furthermor
hrv
strongli
associ
aom
vesa
et
al
clinic
consequ
first
infect
respiratori
virus
sever
follow
repeat
infect
acut
lrt
infect
contribut
morbid
mortal
hiv
infect
malaria
cancer
heart
attack
mizgerd
particular
import
hrv
infect
lrt
morbid
first
year
life
underappreci
kusel
et
al
smallcalibr
immatur
airway
neonat
infant
suscept
poor
outcom
sri
result
airway
swell
excess
secret
smooth
muscl
contract
arti
tabl
hrv
natur
replic
lrt
papadopoulo
et
al
local
inflammatori
effect
feasibl
pathogen
mechan
evid
exist
hrv
replic
nonnas
tissu
includ
smooth
muscl
hakonarson
et
al
bronchial
epitheli
cell
jakiela
et
al
local
effect
must
remot
trigger
urt
hrv
infect
concomit
system
transmiss
immunopatholog
effect
transloc
mediat
lrt
hrv
associ
lrt
wheezi
lrt
ill
hrsv
kusel
et
al
risk
lrt
ill
similar
whether
hrv
hrsv
detect
aberl
et
al
codetect
associ
sever
lrt
ill
detect
hrv
alon
aberl
et
al
sixth
hrv
isolateposit
young
children
exhibit
symptom
lrt
ill
mostli
wheez
frequenc
isol
rise
underli
diseas
involv
immun
tabl
exampl
lrt
symptom
popul
posit
hrv
studi
categori
hrv
frequenc
age
year
gp
andeweg
et
al
gp
glezen
et
al
mostli
outpati
clinic
bloom
et
al
infant
young
children
cystic
fibrosi
collinson
et
al
children
adult
viru
hunt
experiment
dougla
et
al
adult
hospit
bronchiol
et
al
hospit
stott
et
al
hospit
lrt
ill
aberl
et
al
hospit
lrt
ill
krilov
et
al
gp
gener
practition
visit
ili
influenzalik
ill
lrt
lower
respiratori
tract
ill
includ
tracheobronch
bronchiti
bronchiol
laryngotracheobronch
croup
pneumonia
cardiorespiratori
system
exist
krilov
et
al
adult
year
age
durat
symptom
frequenc
lrt
ill
associ
hrv
isol
increas
age
peak
nearli
twothird
total
respiratori
ill
burden
monto
et
al
studi
children
hospitalbas
popul
usual
report
signific
clinic
outcom
especi
relat
lrt
elsahli
et
al
conclus
interpret
cautious
data
consid
condens
sampl
ill
among
communitybas
popul
lrt
ill
identifi
age
patient
group
tabl
hospitalbas
popul
retain
special
import
probe
potenti
viru
caus
sever
clinic
outcom
especi
due
first
infect
case
strongest
influenc
futur
priorit
therapeut
develop
glezen
denni
acut
wheez
episod
includ
bronchiol
acut
asthma
share
similar
patholog
common
epidem
season
lrt
manifest
respiratori
viru
infect
urt
lrt
children
age
especi
among
male
first
year
life
rake
et
al
glezen
et
al
henderson
et
al
glezen
denni
mechan
underli
induct
exacerb
asthma
yet
fulli
understood
martinez
wheez
blame
excess
use
antibiot
primari
caus
hospit
among
children
rare
death
jartti
et
al
pattemor
et
al
exacerb
asthma
copd
often
preced
symptomat
rather
asymptomat
hrv
episod
heymann
et
al
lidwel
sommervil
green
et
al
johnston
et
al
minor
et
al
although
instanc
exacerb
evid
infect
roldaan
masur
reduc
peak
expiratori
volum
children
associ
viral
detect
especi
respiratori
picornavirus
johnston
et
al
bacteri
infect
thought
play
direct
central
role
expiratori
wheez
today
known
acut
asthma
exacerb
age
group
often
ascrib
hrv
infect
elsahli
et
al
johnston
et
al
silva
et
al
presenc
potenti
bacteri
pathogen
alway
reliabl
correl
lrt
sometim
urt
symptom
equival
isol
frequenc
well
children
glezen
denni
significantli
higher
rate
hrv
obviou
lrt
symptom
detect
asthmat
children
nonasthmat
popul
minor
et
al
rawlinson
et
al
pattemor
et
al
asthma
children
also
appear
risk
factor
frequent
symptomat
viral
infect
howev
presenc
atopi
allergi
appear
common
featur
rake
et
al
sinc
small
proport
allerg
children
asthma
yoo
et
al
unclear
risk
atop
asthma
infanc
increas
sri
affect
develop
immun
system
whether
sri
trigger
asthma
develop
children
genet
predisposit
sever
outcom
follow
hrv
infect
hershenson
johnston
gern
buss
martin
et
al
hrsv
infect
also
associ
caus
expiratori
wheez
viru
infect
lrt
yet
report
indic
period
epidem
wheez
unaccompani
high
rate
hrsv
detect
lemansk
henderson
et
al
similar
situat
report
hmpv
infect
rawlinson
et
al
childhood
origin
asthma
studi
coast
use
sampl
criteria
design
intent
investig
role
hrsv
ill
data
indic
hrv
hrsv
import
predictor
subsequ
wheez
earli
childhood
van
der
zalm
et
al
lemansk
et
al
although
total
sri
differ
significantli
asthmat
hrv
infect
sibl
bacteri
infect
sinc
asthmat
often
treat
antibiot
bacteri
detect
rate
may
fals
lower
report
minor
et
al
inhal
corticosteroid
effect
suppress
airway
inflamm
less
effect
prevent
exacerb
initi
hrv
infect
new
experiment
human
mous
model
hrvinduc
diseas
may
provid
evid
causal
role
lrt
symptom
also
prove
use
test
therapeut
efficaci
bartlett
et
al
contrast
influenzaviru
fluav
hrsv
hrv
infect
involv
rel
cell
impart
littl
damag
upon
immun
respons
hrv
infect
thought
drive
ill
drescher
et
al
hendley
sung
et
al
turner
et
al
ex
vivo
studi
peripher
blood
mononuclear
cell
normal
asthmat
subject
identifi
shift
toward
helper
h
respons
hrv
infect
cell
obtain
asthmat
individu
h
respons
manag
humor
immun
stimul
b
cell
via
interleukin
il
initi
product
ige
influenc
eosinophil
crucial
compon
allergeninduc
asthma
h
respons
manag
cellular
immun
produc
two
cell
respons
act
concert
epithelialderiv
chemokin
eg
eotaxin
promot
recruit
activ
eosinophil
mast
cell
contribut
chronic
airway
inflamm
hyperrespons
airway
varieti
nonspecif
stimuli
gern
buss
although
upregul
hrv
infect
h
respons
asthmat
compar
defici
papadopoulo
et
al
mcfadden
wark
et
al
increas
h
cytokin
respons
deduc
higher
sputum
mrna
valu
clear
hrv
rapidli
resolv
symptom
gern
et
al
induct
type
iii
ifn
also
impair
bronchial
epitheli
cell
asthmat
normal
subject
level
invers
associ
hrv
load
symptom
sever
contoli
et
al
protein
rant
induc
hrv
replic
bronchial
cell
former
protein
use
biomark
virusinduc
acut
asthma
associ
sever
airflow
obstruct
reduc
respons
bronchodil
wark
et
al
rise
gcsf
chemoattract
neutrophil
level
urt
protein
detect
nasal
wash
lrt
mrna
sputum
accompani
rise
blood
nasal
neutrophil
number
symptom
sever
normal
atop
individu
gern
et
al
cate
et
al
levandowski
et
al
turner
et
al
hrv
bind
may
modifi
neutrophil
migrat
lymphocytemedi
cytotox
h
interact
hrvinfect
cell
upregul
receptor
express
hakonarson
et
al
apart
proasthmat
chang
respons
tissu
icami
induct
may
also
encourag
eosinophil
cell
infiltr
lower
airway
asthmat
individu
disrupt
normal
neutrophil
traffick
potenti
bacteri
infect
seen
aom
staunton
et
al
martin
et
al
sung
et
al
cell
asthmat
releas
inflammatori
mediat
cell
nonasthmat
yield
higher
viral
load
one
possibl
caus
h
defici
asthmat
inadequ
matur
type
iii
ifn
respons
due
reduc
exposur
infect
earli
life
johnston
hygien
hypothesi
strachan
posit
pathway
develop
allerg
diseas
hay
fever
asthma
condit
rise
preval
postindustri
world
suggest
paediatr
infect
play
role
prevent
allerg
diseas
noteworthi
children
care
day
group
care
set
infect
care
home
wald
et
al
mechan
address
hygien
hypothesi
eloqu
describ
gern
buss
term
young
unchalleng
immun
system
initi
set
toward
h
respons
depend
infect
stimul
develop
h
function
one
intrigu
theori
hrv
infect
play
central
role
develop
efficaci
antivir
immun
particularli
infanc
via
ubiquit
frequent
usual
mild
selflimit
infect
yoo
et
al
older
children
adult
greater
amount
hrvneutral
antibodi
younger
children
use
older
subject
mani
studi
may
limit
observ
seriou
symptomat
outcom
protect
partial
crossprotect
antibodi
moder
effect
consequ
quantifi
level
strainspecif
serum
antibodi
becam
routin
practic
prior
studi
commenc
adult
volunt
infect
studi
determin
infect
result
volunt
preexist
neutral
antibodi
titr
level
grew
level
resist
infect
dick
et
al
hendley
et
al
nonetheless
adult
could
protect
serum
titr
hendley
et
al
dick
et
al
gener
trend
toward
decreas
number
sri
increas
age
trend
broken
spike
isol
adult
year
age
group
presum
children
acquir
bring
current
circul
strain
household
monto
et
al
secret
antihrv
antibodi
mostli
iga
appear
time
serum
antibodi
week
inocul
healthi
adult
volunt
retain
peak
level
least
week
cooney
kenni
cate
et
al
iga
respons
appear
modifi
ill
viru
shed
protect
infect
reinfect
suffici
titr
studi
identifi
adult
without
preexist
nasal
antibodi
experiment
challeng
viru
may
succumb
sever
sri
shed
viru
longer
holm
et
al
buscho
et
al
antibodi
level
nasal
wash
fall
compar
faster
serum
level
buscho
et
al
especi
isol
popul
might
explain
volunt
prestudi
serum
antibodi
presum
iga
still
becom
infect
dick
et
al
cate
et
al
holm
et
al
importantli
evid
degre
nasal
immun
memori
buscho
et
al
symptomat
treatment
analges
decongest
antihistamin
antituss
popular
aim
tabl
prevent
therapeut
approach
target
rhinoviru
infect
therapeut
agent
action
effect
evalu
ref
decreas
shed
administ
within
toxic
rotbart
couch
atmar
hayden
gwaltney
hayden
et
al
pirodavir
capsid
binder
intranas
formul
use
antivir
group
dose
per
day
variabl
efficaci
irrit
mucos
bleed
hayden
et
al
rotbart
win
capsid
binder
broadli
activ
mice
reduc
efficaci
human
rotbart
patick
pleconaril
capsid
binder
resolv
symptom
day
earlier
placebo
strain
resist
fda
issu
approv
letter
side
effect
rotbart
capsid
binder
potent
bind
anim
model
good
bioavail
safeti
profil
anim
phase
trial
complet
ryan
et
al
rupintrivir
formerli
proteas
inhibitor
insignific
impact
discontinu
patick
et
al
rotbart
wang
chen
binford
et
al
enviroxim
potent
antirepl
activ
vitro
sideeffect
vivo
couch
tremacamra
solubl
molecul
could
reduc
experiment
cold
symptom
quantiti
viru
shed
administr
occur
inocul
prior
develop
symptom
turner
et
al
fda
unit
state
food
drug
administr
hrvrelat
intervent
although
use
aspirin
paracetamol
associ
reduc
product
neutral
antibodi
increas
nasal
sign
symptom
increas
likelihood
prolong
viral
shed
graham
et
al
howev
data
limit
effect
overthecount
commoncold
medic
children
smith
feldman
interrupt
proinflammatori
immun
respons
specif
signal
pathway
use
steroid
may
prove
robust
approach
treat
hrv
infect
success
respiratori
virus
associ
expiratori
wheez
gern
buss
initi
earli
ill
combin
antivir
antiinflammatori
compon
show
promis
interrupt
nasal
viral
replic
symptom
antivir
agent
tabl
requir
earli
applic
effect
preced
pathogen
immun
respons
hrv
infect
gern
buss
often
fail
reproduc
vitro
success
vivo
addit
oral
deliveri
complic
drug
safeti
rout
increas
risk
system
side
effect
compar
nasal
topic
rout
system
rout
benefici
effect
sought
viru
replic
site
otherwis
inaccess
associ
respiratori
tract
ill
patick
et
al
capsidbind
compound
attract
interest
antipicornavir
drug
reportedli
act
artifici
stabil
capsid
prevent
uncoat
alter
canyon
floor
perturb
receptor
interact
rotbart
displac
pocket
factor
see
fig
undoubtedli
play
role
mechan
rossmann
et
al
nonetheless
efficaci
variabl
differ
strain
seven
recogn
hrv
b
strain
natur
resist
pleconaril
ledford
et
al
hrv
sensit
two
amino
acid
posit
within
known
interact
pleconaril
implic
natur
resist
phe
leu
replac
tyr
val
ledford
et
al
respect
posit
alon
confer
signific
impact
differ
permut
substitut
creat
gradient
resist
chang
posit
confer
complet
resist
demonstr
resist
hrv
b
strain
ledford
et
al
antivir
must
taken
earli
frequent
signific
impact
ill
prophylact
use
highli
sequencespecif
treatment
may
undesir
due
like
develop
antivir
resist
consid
may
day
patient
seek
medic
care
arti
linder
despit
belief
impend
cold
identifi
within
h
first
symptom
gwaltney
seem
unlik
drug
use
suitabl
effect
antivir
therapeut
current
best
employ
compassion
use
popul
high
risk
poor
clinic
outcom
unserotyp
hrv
isol
report
prior
krilov
et
al
monto
et
al
advent
pcr
object
rapid
identif
unassigneduntyp
picornavirus
upv
continu
molecular
level
fig
johnston
et
al
deffernez
et
al
savolainen
et
al
loen
et
al
arden
et
al
lamson
et
al
jartti
et
al
initi
retrospect
pcrbase
investig
respiratori
specimen
identifi
dichotom
cluster
around
dozen
potenti
upv
arden
et
al
mcerlean
et
al
share
limit
ident
subgenom
code
sequenc
resid
genbank
propos
belong
hrv
strain
compris
novel
clade
hrv
speci
call
hrv
arden
et
al
similar
subgenom
sequenc
subsequ
found
unit
state
lamson
et
al
renwick
et
al
indic
global
distribut
put
new
hrv
sinc
signific
similar
first
upv
sequenc
describ
investig
result
complet
polyprotein
code
sequenc
fig
hrv
strain
hrvqpm
prove
first
identif
character
perform
sole
molecular
mean
first
novel
hrv
describ
although
yet
isol
two
decad
complet
code
sequenc
similar
uncultur
strain
subsequ
report
two
hrvx
adult
asthma
studi
unit
state
kistler
et
al
three
hrvc
detect
paediatr
popul
studi
hbov
lau
et
al
hong
kong
genom
hrv
c
strain
shorter
compar
higher
g
c
content
bias
toward
wobbl
posit
certain
codon
known
hrv
region
share
greater
amino
acid
ident
member
hrv
pro
region
similar
hrv
b
strain
fig
sign
recombin
identifi
date
hrvqpm
sequenc
far
diverg
hrv
investig
detail
mcerlean
et
al
across
subgenom
region
current
employ
assign
speci
genu
rhinoviru
hrv
clike
strain
genet
distinct
share
averag
amino
acid
ident
nearest
speci
retain
ident
ascrib
strain
speci
strictli
purvey
ictv
howev
featur
strongli
suggest
strain
previous
defin
hrv
clade
redefin
novel
speci
hrv
could
entitl
human
rhinoviru
c
hrv
c
previous
initi
lau
et
al
expand
upon
mcerlean
et
al
independ
consider
picornaviru
studi
group
http
wwwpicornastudygroupcom
nonetheless
sever
tradit
phenotyp
trait
includ
acid
stabil
neutral
pattern
receptor
usag
antivir
suscept
current
qualifi
delay
reliabl
taxonom
placement
sought
fig
distil
signific
event
histori
hrv
research
antivir
mileston
downward
face
arrow
box
recognis
signific
public
may
repres
first
use
human
hexagonsreport
untypeableunassign
picornaviru
sequenc
deriv
pcr
product
starscomplet
code
sequenc
hrv
c
strain
triangleslaboratori
data
suggest
new
hrv
speci
hrv
c
address
creat
computerbas
model
hrvqpm
date
hrvqpm
individu
hrv
strain
diverg
tradit
part
deliber
pcrbase
preval
studi
use
specimen
popul
screen
tradit
newli
identifi
virus
viral
group
largest
peak
hrvqpm
preval
follow
return
school
break
second
midyear
fig
genom
featur
hrv
c
strain
hrv
genom
depict
promin
code
polyprotein
featur
mark
b
plot
averag
amino
acid
sequenc
ident
region
six
hrv
c
strain
compar
region
hrv
speci
hrv
grey
line
hrv
b
black
highest
mean
predict
amino
acid
ident
indic
dash
line
specif
valu
closest
match
speci
construct
use
simplot
http
sraymedsomjhmieduscroftwar
use
ham
distanc
model
slide
window
aa
step
aa
adapt
mackay
et
al
pressa
persist
cough
commun
b
unit
state
lamson
et
al
month
year
year
respiratori
swab
arti
birth
cohort
unit
state
month
nasal
lavag
sriyr
hospit
hbov
studi
hong
kong
lau
et
al
day
year
npa
fever
expiratori
wheez
withwithout
asthma
unit
state
kistler
et
al
adult
nasal
lavag
urt
ill
hospit
renwick
et
al
children
npa
arti
arti
acut
respiratori
tract
infect
lrt
lower
respiratori
tract
npa
nasopharyng
aspir
includ
inpati
outpati
b
visit
health
care
provid
fourth
end
year
term
holiday
mcerlean
et
al
variant
identifi
infant
endur
mild
sever
sri
commonli
manifest
acut
expiratori
wheez
hrvqpm
detect
persist
cough
commonli
hrvqpm
accompani
anoth
viru
usual
requir
hospit
often
receiv
supplement
oxygen
hrvqpm
viru
found
detect
mcerlean
et
al
mcerlean
et
al
investig
date
yield
hrvqpm
variant
europ
unit
state
elsewher
australia
indic
global
probabl
endem
circul
tempt
propos
hrv
cs
may
yield
sourc
strain
frequent
associ
expiratori
wheez
lau
et
al
mcerlean
et
al
pneumonia
undefin
renwick
et
al
studi
conduct
signific
differ
clinic
outcom
tabl
littl
known
impact
individu
hrv
b
strain
current
cultiv
hrv
c
strain
report
despit
inocul
mani
tradit
cell
line
silico
analys
predict
likelihood
hrvqpm
employ
vldlr
receptor
slim
icamlik
molecul
may
probabl
candid
mcerlean
et
al
new
strain
contain
delet
larg
bc
de
hi
loop
fig
includ
thr
could
convey
natur
resist
pleconaril
lau
et
al
impact
hrv
c
strain
efficaci
current
antivir
design
may
signific
evid
exist
suggest
hrv
c
strain
emerg
new
virus
discoveri
requir
novel
molecular
techniqu
prove
necessari
vigil
character
upv
appear
hrv
c
strain
newli
identifi
virus
mackay
et
al
pressb
contribut
sri
absenc
detect
least
decad
intriguingli
hand
gama
assay
gama
et
al
continu
detect
hrv
even
newli
identifi
highli
diverg
strain
impress
consid
eight
complet
genom
resid
public
domain
mostli
appear
number
genom
sequenc
increas
nearli
kistler
et
al
tapparel
et
al
mcerlean
et
al
lau
et
al
kistler
et
al
sequenc
tradit
hrv
strain
avail
soon
rath
interpret
deriv
literatur
ongo
studi
suggest
could
mani
hrv
strain
circul
ascrib
new
exist
speci
current
known
hrv
strain
furthermor
diverg
virus
may
novel
fastidi
requir
cultiv
util
differ
molecul
receptor
circul
specif
season
unexpectedli
resist
antivir
perhap
associ
specif
clinic
outcom
interest
field
rhinovirolog
rise
attent
long
overdu
earli
studi
adult
older
children
perhap
defin
mild
clinic
impact
still
associ
infect
common
cold
virus
possibl
detract
character
popul
viral
supergroup
emerg
hiv
also
undermin
hrv
character
common
cold
could
hardli
compet
aid
research
dollar
tyrrel
fielder
howev
emerg
sarscov
may
return
respiratori
viru
hunt
research
radar
work
field
imposs
ignor
domin
hrv
infect
mani
aspect
respiratori
tract
ill
thank
research
held
ground
hrv
research
less
popular
continu
produc
import
immunobiolog
virolog
data
investig
role
hrv
immun
develop
identifi
greater
impact
among
host
certain
immun
defici
previou
studi
weaken
unreli
cultiv
techniqu
labori
possibl
crossreact
serolog
method
confound
seemingli
random
contribut
upv
hrv
epidemiolog
problem
confus
definit
hrv
infect
frequenc
extent
clinic
impact
earli
childhood
ill
know
hrv
play
central
role
expiratori
wheez
contribut
develop
antibiot
resist
associ
hospit
children
neg
virus
find
driven
improv
diagnost
capac
aid
increas
popular
viru
hunt
clearli
clinic
infecti
diseas
studi
signific
power
pathogen
must
first
identifi
comprehens
character
alreadi
appar
modern
tool
greater
attent
hrv
meant
earlier
associ
respiratori
ill
infect
singl
tradit
virus
retain
signific
today
limit
data
comprehens
address
hrv
strainspecif
circul
pattern
antivir
resist
sequenc
variabl
possibl
robust
associ
hrv
strain
speci
specif
clinic
outcom
also
know
extent
involv
finetun
perhap
develop
aspect
immunolog
defenc
yet
hrv
seem
play
role
johnston
openshaw
today
renew
interest
hrv
fuell
molecular
character
tradit
hrv
genom
discoveri
diverg
strain
time
address
unansw
question
litter
particularli
neglect
battlefield
one
mani
war
virus
human
host
